July 14, 2020, Vol 324, No. 2, Pages 121-206
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich, MD; John R. Mascola, MD; Myron S. Cohen, MD
free access has multimedia
JAMA. 2020;324(2):131-132. doi:10.1001/jama.2020.10245
This Viewpoint discusses the potential role of neutralizing monoclonal antibodies (MAbs) as a treatment for coronavirus disease 2019 (COVID-19) and as a means of prevention in high-risk populations, and it also raises possible limitations of the approach that need to be disproven or addressed for the strategy to be effective.